NeuroSense Therapeutics
NRSN
NRSN
7 hedge funds and large institutions have $733K invested in NeuroSense Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citigroup
New York
|
$168K |
| 2 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
$134K |
| 3 |
Jane Street
New York
|
$261K |
| 4 |
Millennium Management
New York
|
$68K |
| 5 |
UBS Group
Zurich,
Switzerland
|
$45K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $261K | +$114K | +33,751 | +78% |
|
|
2
Citigroup
New York
| $168K | +$168K | +49,734 | +497,340% |
|
|
VPIM
3
Vanguard Personalized Indexing Management
Oakland,
California
| $134K | +$134K | +39,634 | New |
|
|
4
Millennium Management
New York
| $68K | +$68K | +20,259 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $45K | +$38.7K | +11,544 | +613% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $33K | +$32K | +9,494 | +3,165% |
|
|
CS
7
Clear Street
New York
| $24K | +$24K | +7,157 | New |
|
|
IC
8
Ikarian Capital
Dallas,
Texas
| – | -$397K | -100,000 | Closed |
|
|
BFM
9
Boothbay Fund Management
New York
| – | -$48K | -12,170 | Closed |
|
10
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$65K | -10,000 | Closed |
|
|
FIA
11
FNY Investment Advisers
New York
| – | -$3K | -1,000 | Closed |
|